Solve ME/CFS Initiative
Overview
Solve ME/CFS Initiative is a non-profit organization that serves as a catalyst for research into diagnostics, treatments, and cures for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Long Covid, and other infection-associated chronic illnesses by investing in scientific studies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Biovista | Mar 2012 | Grant | Co-investor |
| Tea Leaf Health | Apr 2025 | Grant | Co-investor |
Key People
Emily Taylor
President And CEO
Jessica Maya
Vice President Of Scientific Programs
Brett Balzer
Member Of Emeritus Board Of Directors
Elissa Regan
Director Of Advancement
Erin Gary
Director Of Operations
Janice Stanton
Member Board Of Directors
Monique W.
Advocacy Director
Rick Sprout
Member Board Of Directors -- Chair Nominating Committee
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Solve ME/CFS Initiative based?
Solve ME/CFS Initiative is headquartered in Glendale, California, United States.
When was Solve ME/CFS Initiative founded?
Solve ME/CFS Initiative was founded in 1987.
How many portfolio companies does Solve ME/CFS Initiative have?
Solve ME/CFS Initiative has 2 portfolio companies in Caplight's dataset.
What are some companies in Solve ME/CFS Initiative's portfolio?
Portfolio companies visible on Caplight include Biovista, Tea Leaf Health.
What was Solve ME/CFS Initiative's most recent investment shown here?
Solve ME/CFS Initiative's most recent investment in this portfolio sample was in Tea Leaf Health in 2025.
What sectors does Solve ME/CFS Initiative focus on?
Solve ME/CFS Initiative focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure.
What company stages does Solve ME/CFS Initiative focus on?
Stage focus information for Solve ME/CFS Initiative is not publicly available.